Joel Greenblatt's position in 10x Genomics is currently worth $161 Thousand. That's 0.00% of their equity portfolio (1296th largest holding). The first 10x Genomics trade was made in Q1 2023. Since then Joel Greenblatt bought shares four more times and sold shares on one occasions. The investor's estimated purchase price is $290 Thousand, resulting in a loss of 44%.